Breaking News: Biosynex and Chembio Diagnostics Join Forces in Definitive Acquisition Agreement!

Biosynex and Chembio Diagnostics Announce Definitive Agreement to Merge Complementary Technologies and Market Opportunities Drive Merger In a move expected to shake up the medical diagnostics industry, Biosynex SA and Chembio Diagnostics have announced a definitive agreement to merge. The merger will combine Biosynex’s expertise in the design and distribution of rapid tests with Chembio…

Read More

Oops, Vornado’s Got Some Explaining to Do: Non-Cash Impairment Charges to Shake Up Fourth Quarter 2022 Financial Results!

Oh No! Vornado Announces Non-Cash Impairment Charges What Does This Mean? So, apparently Vornado Realty Trust is taking a bit of a hit with approximately $600 million in non-cash impairment charges for the quarter ended December 31, 2022. Ouch! That’s gotta hurt. Delving Deeper It seems like a big chunk of that amount, around $480…

Read More

Revolutionizing Heart Health: LumiraDX’s Point-of-Care NT-proBNP Test Now Available in Europe for Commercial Shipment, Empowering UK’s Heart Health Checks

LumiraDx Announces Commercial Shipment of its Point of Care NT-proBNP Test in Europe, Supporting Faster Diagnosis and Treatment Introduction Run on the highly portable LumiraDx Platform, the LumiraDx NT-proBNP test is a quantitative, fingerstick blood assay designed for near-patient testing with lab-comparable results in 12 minutes. It is the only fingerstick NT-proBNP test currently commercially…

Read More

First Guaranty Announces Impressive Financial Results for 2022: Net Income of $28.9 Million and Earnings Per Share of $2.48

First Guaranty Announces Impressive Financial Results for 2022 Net Income of $28.9 Million and Earnings Per Share of $2.48 HAMMOND, La., Jan. 31, 2023 (GLOBE NEWSWIRE) — First Guaranty Bancshares, Inc. (“First Guaranty”) (NASDAQ: FGBI), the holding company for First Guaranty Bank, announced its unaudited financial results for the quarter and year ending December 31,…

Read More

Breaking News: Nemaura Medical Successfully Closes $8.4 Million Registered Direct Offering and Private Placement

Breaking News: Nemaura Medical Successfully Closes $8.4 Million Registered Direct Offering and Private Placement LOUGHBOROUGH, Jan. 31, 2023 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable sensors and supporting personalized lifestyle and weight reduction programs, today announced the close of…

Read More

Christianacare Takes a Bold Step Towards Equity: Introducing Their Supplier Diversity Program

ChristianaCare Launches Supplier Diversity Program Program makes the organization more reflective of the patients and communities it serves WILMINGTON, Delaware, Jan. 31, 2023 (GLOBE NEWSWIRE) — To advance its commitment to diversity and inclusion, ChristianaCare has launched a supplier diversity program – the first among hospitals in Delaware – that supports greater equity among suppliers…

Read More

Unleashing the Power of Brand Engagement: DemandLab Makes the 2023 Chief Marketer 200 Exclusive List!

Welcome to DemandLab: A Leader in B2B Martech Global B2B Digital Marketing Agency Included on List of Top 200 Brand Engagement and Experience Agencies PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) — For the second year in a row, Global enterprise B2B digital marketing agency and marketing-led customer experience innovator DemandLab has been named to the…

Read More

Breaking News: The Producto Group’s Strategic Growth Soars with New CEO, Medtech Veteran on Board, and Fresh Website!

The Producto Group Continues its Strategic Growth with Appointment of CEO, Addition of MedTech Veteran Board Member New York, Jan. 31, 2023 (GLOBE NEWSWIRE) — The Producto Group (the “Company” or “Producto”), a solution driven manufacturer of high-precision round tooling, precision machining and assemblies for complex components and heavy-gauge custom plastic enclosures, announced today that…

Read More